Streetbeat News

Regulatory

FXI

White House National Security Adviser and Chinese officials engaged in candid and constructive discussions on various bilateral, regional, and global issues, as reported by Reuters citing a White House statement.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:42 pm

ATOS

Atossa Therapeutics has been granted a new patent for compositions comprising Endoxifen and an anteric material, where at least 90% of the Endoxifen is (Z)-Endoxifen. This patent could enhance Atossa's intellectual property portfolio and potentially impact its market position.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:33 pm

ICCM

IceCure Medical Ltd. (NASDAQ:ICCM) has received a Notice of Allowance from the USPTO for a continuation patent on its 'Cryogenic Pump' technology, enhancing its global IP leadership in cryoablation technologies. This patent broadens the applications of IceCure's platform, with over 50 patents issued worldwide.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:32 pm

AZTR

Azitra has initiated a Phase 1b clinical trial for ATR-12, targeting Netherton Syndrome. The trial will involve 12 adults over 14 days, with interim safety data expected in early 2025 and full results in the second half of 2025.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:31 pm

WATT

Energous Corporation (NASDAQ:WATT) has received full FCC certification for its 2W PowerBridge transmitter system, marking it as the first certified transmitter at this power level. This system enhances wireless power networks by providing up to 8W EIRP, improving supply chain visibility and enabling continuous wireless power and real-time data for connected devices.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:31 pm

ARQT

Arcutis Biotherapeutics reported positive long-term results from its INTEGUMENT-OLE study, demonstrating the efficacy and safety of Roflumilast Cream 0.05% for treating mild to moderate atopic dermatitis in children. The company plans to submit a supplemental New Drug Application (sNDA) to the FDA in Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:07 pm

GMGI

Golden Matrix Group is expanding its presence in the iGaming market by applying for a license in New Jersey, obtaining a license in Bulgaria, and targeting Brazil's $20 billion market through its subsidiary, Meridianbet.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:06 pm

BIOR

Biora Therapeutics has been granted an extension by Nasdaq to regain compliance with its listing requirements. This extension provides the company with additional time to meet the necessary criteria to remain listed on the exchange.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:01 pm

BTCUSD

Arthur Hayes, co-founder of BitMEX, suggests that the Federal Reserve's monetary policy may be influenced by the upcoming U.S. presidential election, potentially leading to interest rate cuts to stimulate the stock market. This could result in increased liquidity and a bullish market sentiment.

Portfolio Pulse from Murtuza Merchant

August 28, 2024 | 11:39 am

COSM

VRAX

Virax Biolabs Group Limited (NASDAQ:VRAX) has signed a distribution agreement for Mpox virus detection kits in Europe and the Middle East. The kits are approved for sale in Europe and authorized by the UK's regulatory agency. Cosmos Health Inc. (NASDAQ:COSM) retains distribution rights in Greece, Cyprus, and non-exclusive rights across Europe. VRAX stock was down 4.70% in premarket trading.

Portfolio Pulse from Vandana Singh

August 28, 2024 | 11:16 am